🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Tactile Systems CFO sells shares worth over $41k

Published 05/20/2024, 04:38 PM
TCMD
-

Tactile Systems Technology Inc 's (NASDAQ:TCMD) Chief Financial Officer, Elaine M. Birkemeyer, has recently sold company shares, according to the latest SEC filings. On May 16, 2024, Birkemeyer sold 3,041 shares of common stock at prices ranging from $13.67 to $13.69, totaling approximately $41,589.

The transactions were executed to cover taxes associated with the settlement of stock units, as indicated in the footnotes of the filing. Following the sale, Birkemeyer's direct ownership in the company stands at 61,295 shares of common stock.

Investors often monitor insider transactions as they may provide insights into the company’s performance and the confidence level of its executives. The sale by Birkemeyer comes at a time when market participants are closely watching insider activity for signals about the future direction of the company's stock.

Tactile Systems Technology Inc, headquartered in Minneapolis, Minnesota, specializes in medical devices, particularly in the field of surgical and medical instruments and apparatus. The sale by the CFO is part of the regular disclosure of stock transactions by company insiders.

For those interested in the specifics of the transaction, Birkemeyer has committed to providing full information regarding the number of shares sold at each separate price upon request by the SEC, the issuer, or a security holder of the issuer.

This recent filing gives a snapshot of insider activity and is part of the ongoing reporting that provides transparency for investors and the market.

InvestingPro Insights

As Tactile Systems Technology Inc (NASDAQ:TCMD) navigates the market, recent transactions by the company's CFO have caught the attention of investors. In the midst of these developments, let's delve into some key metrics and insights that could shed light on the company's financial health and future prospects.

The company's market capitalization stands at a modest $324.35M, reflecting its position in the medical device sector. A notable point for investors is the company's Price-to-Earnings (P/E) ratio, which currently stands at 11.43, suggesting a potentially undervalued stock compared to industry peers. When looking at the adjusted P/E ratio for the last twelve months as of Q1 2024, this figure slightly increases to 12.72, indicating a stable earnings outlook.

InvestingPro Tips provide a deeper dive into the company's financial nuances. With a high shareholder yield and a valuation that implies a strong free cash flow yield, TCMD appears to be managing its financials prudently. Notably, analysts have revised their earnings upwards for the upcoming period, signaling optimism about the company's profitability. Additionally, TCMD operates with a moderate level of debt and has liquid assets that exceed short-term obligations, which may offer some reassurance about the company's ability to meet its financial commitments.

For those seeking comprehensive analysis and additional insights, there are 9 more InvestingPro Tips available for TCMD at InvestingPro. To enhance your investment research, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

While insider transactions such as the CFO's recent sale can offer a glimpse into the confidence levels of company executives, it's essential to consider the broader financial context provided by these InvestingPro metrics and tips.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.